NEFH and proximal spinal muscular atrophy: While blood NfH levels effectively indicated disease onset and transiently responded to ASOs treatment in mice, despite persistent therapeutic benefits, NfH levels showed a dramatic 90% decrease during early postnatal development in both control and SMA mice (Spicer et al. [43]).